APO Research
Talk to an analyst

APO RESEARCH · REPORT

GABAA Receptor Agonists

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global GABAA Receptor Agonists Market Analysis and Forecast 2026-2032

21 December 2025219 pages

Choose your research edition.

Industry ResearchGABAA Receptor Agonists Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal GABAA Receptor Agonists Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal GABAA Receptor Agonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GABAA Receptor Agonists Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal GABAA Receptor Agonists Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global GABAA Receptor Agonists market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for GABAA Receptor Agonists is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for GABAA Receptor Agonists is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for GABAA Receptor Agonists is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for GABAA Receptor Agonists is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of GABAA Receptor Agonists include Takeda, Teva, Sun Pharma, Shanghai Pharmaceuticals Holding, Sandoz, Sanofi, Novartis, Mylan and Roche, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for GABAA Receptor Agonists, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of GABAA Receptor Agonists, also provides the sales of main regions and countries. Of the upcoming market potential for GABAA Receptor Agonists, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the GABAA Receptor Agonists sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global GABAA Receptor Agonists market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for GABAA Receptor Agonists sales, projected growth trends, production technology, application and end-user industry.

GABAA Receptor Agonists Segment by Company

Takeda

Teva

Sun Pharma

Shanghai Pharmaceuticals Holding

Sandoz

Sanofi

Novartis

Mylan

Roche

Pfizer

Huazhong Pharmaceutical

Sichuan HaiscoPharmaceuical

GSK

Fresenius Kabi

Changzhou Siyao Pharmaceutical

AstraZeneca

WG Critical Care

Viatris

Torrent Pharma

SAGE Therapeutics

Neurelis

Hikma

CHEPLAPHARM

Apotex

Akorn

GABAA Receptor Agonists Segment by Type

BZDs

Non-BZDs

GABAA Receptor Agonists Segment by Application

Epilepsy

Anxiety

Neuropathic Pain

Insomnia

Other

GABAA Receptor Agonists Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GABAA Receptor Agonists market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GABAA Receptor Agonists and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GABAA Receptor Agonists.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of GABAA Receptor Agonists in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of GABAA Receptor Agonists manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, GABAA Receptor Agonists sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global GABAA Receptor Agonists Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. BZDs Major Manufacturers Table 3. Non-BZDs Major Manufacturers Table 4. Global GABAA Receptor Agonists Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Epilepsy Major Manufacturers Table 6. Anxiety Major Manufacturers Table 7. Neuropathic Pain Major Manufacturers Table 8. Insomnia Major Manufacturers Table 9. Other Major Manufacturers Table 10. GABAA Receptor Agonists Industry Trends Table 11. GABAA Receptor Agonists Industry Drivers Table 12. GABAA Receptor Agonists Industry Opportunities and Challenges Table 13. GABAA Receptor Agonists Industry Restraints Table 14. Global GABAA Receptor Agonists Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global GABAA Receptor Agonists Revenue by Region (2021-2026) & (US$ Million) Table 16. Global GABAA Receptor Agonists Revenue by Region (2027-2032) & (US$ Million) Table 17. Global GABAA Receptor Agonists Revenue Market Share by Region (2021-2026) Table 18. Global GABAA Receptor Agonists Revenue Market Share by Region (2027-2032) Table 19. Global GABAA Receptor Agonists Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 20. Global GABAA Receptor Agonists Sales by Region (2021-2026) & (k units) Table 21. Global GABAA Receptor Agonists Sales by Region (2027-2032) & (k units) Table 22. Global GABAA Receptor Agonists Sales Market Share by Region (2021-2026) Table 23. Global GABAA Receptor Agonists Sales Market Share by Region (2027-2032) Table 24. Global GABAA Receptor Agonists Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global GABAA Receptor Agonists Revenue Market Share by Manufacturers (2021-2026) Table 26. Global GABAA Receptor Agonists Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global GABAA Receptor Agonists Sales Market Share by Manufacturers (2021-2026) Table 28. Global GABAA Receptor Agonists Sales Price (US$/unit) of Manufacturers (2021-2026) Table 29. Global GABAA Receptor Agonists Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global GABAA Receptor Agonists Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global GABAA Receptor Agonists Manufacturers, Product Type & Application Table 32. Global GABAA Receptor Agonists Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global GABAA Receptor Agonists by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global GABAA Receptor Agonists Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global GABAA Receptor Agonists Revenue by Type (2021-2026) & (US$ Million) Table 37. Global GABAA Receptor Agonists Revenue by Type (2027-2032) & (US$ Million) Table 38. Global GABAA Receptor Agonists Revenue Market Share by Type (2021-2026) Table 39. Global GABAA Receptor Agonists Revenue Market Share by Type (2027-2032) Table 40. Global GABAA Receptor Agonists Sales by Type 2021 VS 2025 VS 2032 (k units) Table 41. Global GABAA Receptor Agonists Sales by Type (2021-2026) & (k units) Table 42. Global GABAA Receptor Agonists Sales by Type (2027-2032) & (k units) Table 43. Global GABAA Receptor Agonists Sales Market Share by Type (2021-2026) Table 44. Global GABAA Receptor Agonists Sales Market Share by Type (2027-2032) Table 45. Global GABAA Receptor Agonists Price by Type (2021-2026) & (US$/unit) Table 46. Global GABAA Receptor Agonists Price by Type (2027-2032) & (US$/unit) Table 47. Global GABAA Receptor Agonists Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global GABAA Receptor Agonists Revenue by Application (2021-2026) & (US$ Million) Table 49. Global GABAA Receptor Agonists Revenue by Application (2027-2032) & (US$ Million) Table 50. Global GABAA Receptor Agonists Revenue Market Share by Application (2021-2026) Table 51. Global GABAA Receptor Agonists Revenue Market Share by Application (2027-2032) Table 52. Global GABAA Receptor Agonists Sales by Application 2021 VS 2025 VS 2032 (k units) Table 53. Global GABAA Receptor Agonists Sales by Application (2021-2026) & (k units) Table 54. Global GABAA Receptor Agonists Sales by Application (2027-2032) & (k units) Table 55. Global GABAA Receptor Agonists Sales Market Share by Application (2021-2026) Table 56. Global GABAA Receptor Agonists Sales Market Share by Application (2027-2032) Table 57. Global GABAA Receptor Agonists Price by Application (2021-2026) & (US$/unit) Table 58. Global GABAA Receptor Agonists Price by Application (2027-2032) & (US$/unit) Table 59. Takeda Company Information Table 60. Takeda Business Overview Table 61. Takeda GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 62. Takeda GABAA Receptor Agonists Product Portfolio Table 63. Takeda Recent Development Table 64. Teva Company Information Table 65. Teva Business Overview Table 66. Teva GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Teva GABAA Receptor Agonists Product Portfolio Table 68. Teva Recent Development Table 69. Sun Pharma Company Information Table 70. Sun Pharma Business Overview Table 71. Sun Pharma GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Sun Pharma GABAA Receptor Agonists Product Portfolio Table 73. Sun Pharma Recent Development Table 74. Shanghai Pharmaceuticals Holding Company Information Table 75. Shanghai Pharmaceuticals Holding Business Overview Table 76. Shanghai Pharmaceuticals Holding GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Shanghai Pharmaceuticals Holding GABAA Receptor Agonists Product Portfolio Table 78. Shanghai Pharmaceuticals Holding Recent Development Table 79. Sandoz Company Information Table 80. Sandoz Business Overview Table 81. Sandoz GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Sandoz GABAA Receptor Agonists Product Portfolio Table 83. Sandoz Recent Development Table 84. Sanofi Company Information Table 85. Sanofi Business Overview Table 86. Sanofi GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Sanofi GABAA Receptor Agonists Product Portfolio Table 88. Sanofi Recent Development Table 89. Novartis Company Information Table 90. Novartis Business Overview Table 91. Novartis GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Novartis GABAA Receptor Agonists Product Portfolio Table 93. Novartis Recent Development Table 94. Mylan Company Information Table 95. Mylan Business Overview Table 96. Mylan GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Mylan GABAA Receptor Agonists Product Portfolio Table 98. Mylan Recent Development Table 99. Roche Company Information Table 100. Roche Business Overview Table 101. Roche GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Roche GABAA Receptor Agonists Product Portfolio Table 103. Roche Recent Development Table 104. Pfizer Company Information Table 105. Pfizer Business Overview Table 106. Pfizer GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Pfizer GABAA Receptor Agonists Product Portfolio Table 108. Pfizer Recent Development Table 109. Huazhong Pharmaceutical Company Information Table 110. Huazhong Pharmaceutical Business Overview Table 111. Huazhong Pharmaceutical GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Huazhong Pharmaceutical GABAA Receptor Agonists Product Portfolio Table 113. Huazhong Pharmaceutical Recent Development Table 114. Sichuan HaiscoPharmaceuical Company Information Table 115. Sichuan HaiscoPharmaceuical Business Overview Table 116. Sichuan HaiscoPharmaceuical GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Sichuan HaiscoPharmaceuical GABAA Receptor Agonists Product Portfolio Table 118. Sichuan HaiscoPharmaceuical Recent Development Table 119. GSK Company Information Table 120. GSK Business Overview Table 121. GSK GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. GSK GABAA Receptor Agonists Product Portfolio Table 123. GSK Recent Development Table 124. Fresenius Kabi Company Information Table 125. Fresenius Kabi Business Overview Table 126. Fresenius Kabi GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 127. Fresenius Kabi GABAA Receptor Agonists Product Portfolio Table 128. Fresenius Kabi Recent Development Table 129. Changzhou Siyao Pharmaceutical Company Information Table 130. Changzhou Siyao Pharmaceutical Business Overview Table 131. Changzhou Siyao Pharmaceutical GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 132. Changzhou Siyao Pharmaceutical GABAA Receptor Agonists Product Portfolio Table 133. Changzhou Siyao Pharmaceutical Recent Development Table 134. AstraZeneca Company Information Table 135. AstraZeneca Business Overview Table 136. AstraZeneca GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 137. AstraZeneca GABAA Receptor Agonists Product Portfolio Table 138. AstraZeneca Recent Development Table 139. WG Critical Care Company Information Table 140. WG Critical Care Business Overview Table 141. WG Critical Care GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 142. WG Critical Care GABAA Receptor Agonists Product Portfolio Table 143. WG Critical Care Recent Development Table 144. Viatris Company Information Table 145. Viatris Business Overview Table 146. Viatris GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 147. Viatris GABAA Receptor Agonists Product Portfolio Table 148. Viatris Recent Development Table 149. Torrent Pharma Company Information Table 150. Torrent Pharma Business Overview Table 151. Torrent Pharma GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 152. Torrent Pharma GABAA Receptor Agonists Product Portfolio Table 153. Torrent Pharma Recent Development Table 154. SAGE Therapeutics Company Information Table 155. SAGE Therapeutics Business Overview Table 156. SAGE Therapeutics GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 157. SAGE Therapeutics GABAA Receptor Agonists Product Portfolio Table 158. SAGE Therapeutics Recent Development Table 159. Neurelis Company Information Table 160. Neurelis Business Overview Table 161. Neurelis GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 162. Neurelis GABAA Receptor Agonists Product Portfolio Table 163. Neurelis Recent Development Table 164. Hikma Company Information Table 165. Hikma Business Overview Table 166. Hikma GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 167. Hikma GABAA Receptor Agonists Product Portfolio Table 168. Hikma Recent Development Table 169. CHEPLAPHARM Company Information Table 170. CHEPLAPHARM Business Overview Table 171. CHEPLAPHARM GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 172. CHEPLAPHARM GABAA Receptor Agonists Product Portfolio Table 173. CHEPLAPHARM Recent Development Table 174. Apotex Company Information Table 175. Apotex Business Overview Table 176. Apotex GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 177. Apotex GABAA Receptor Agonists Product Portfolio Table 178. Apotex Recent Development Table 179. Akorn Company Information Table 180. Akorn Business Overview Table 181. Akorn GABAA Receptor Agonists Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 182. Akorn GABAA Receptor Agonists Product Portfolio Table 183. Akorn Recent Development Table 184. North America GABAA Receptor Agonists Revenue by Type (2021-2026) & (US$ Million) Table 185. North America GABAA Receptor Agonists Revenue by Type (2027-2032) & (US$ Million) Table 186. North America GABAA Receptor Agonists Sales by Type (2021-2026) & (k units) Table 187. North America GABAA Receptor Agonists Sales by Type (2027-2032) & (k units) Table 188. North America GABAA Receptor Agonists Sales Price by Type (2021-2026) & (US$/unit) Table 189. North America GABAA Receptor Agonists Sales Price by Type (2027-2032) & (US$/unit) Table 190. North America GABAA Receptor Agonists Revenue by Application (2021-2026) & (US$ Million) Table 191. North America GABAA Receptor Agonists Revenue by Application (2027-2032) & (US$ Million) Table 192. North America GABAA Receptor Agonists Sales by Application (2021-2026) & (k units) Table 193. North America GABAA Receptor Agonists Sales by Application (2027-2032) & (k units) Table 194. North America GABAA Receptor Agonists Sales Price by Application (2021-2026) & (US$/unit) Table 195. North America GABAA Receptor Agonists Sales Price by Application (2027-2032) & (US$/unit) Table 196. North America GABAA Receptor Agonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 197. North America GABAA Receptor Agonists Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 198. North America GABAA Receptor Agonists Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 199. North America GABAA Receptor Agonists Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 200. North America GABAA Receptor Agonists Sales by Country (2021-2026) & (k units) Table 201. North America GABAA Receptor Agonists Sales by Country (2027-2032) & (k units) Table 202. North America GABAA Receptor Agonists Sales Price by Country (2021-2026) & (US$/unit) Table 203. North America GABAA Receptor Agonists Sales Price by Country (2027-2032) & (US$/unit) Table 204. United States GABAA Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 205. Canada GABAA Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 206. Mexico GABAA Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 207. Europe GABAA Receptor Agonists Revenue by Type (2021-2026) & (US$ Million) Table 208. Europe GABAA Receptor Agonists Revenue by Type (2027-2032) & (US$ Million) Table 209. Europe GABAA Receptor Agonists Sales by Type (2021-2026) & (k units) Table 210. Europe GABAA Receptor Agonists Sales by Type (2027-2032) & (k units) Table 211. Europe GABAA Receptor Agonists Sales Price by Type (2021-2026) & (US$/unit) Table 212. Europe GABAA Receptor Agonists Sales Price by Type (2027-2032) & (US$/unit) Table 213. Europe GABAA Receptor Agonists Revenue by Application (2021-2026) & (US$ Million) Table 214. Europe GABAA Receptor Agonists Revenue by Application (2027-2032) & (US$ Million) Table 215. Europe GABAA Receptor Agonists Sales by Application (2021-2026) & (k units) Table 216. Europe GABAA Receptor Agonists Sales by Application (2027-2032) & (k units) Table 217. Europe GABAA Receptor Agonists Sales Price by Application (2021-2026) & (US$/unit) Table 218. Europe GABAA Receptor Agonists Sales Price by Application (2027-2032) & (US$/unit) Table 219. Europe GABAA Receptor Agonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 220. Europe GABAA Receptor Agonists Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 221. Europe GABAA Receptor Agonists Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 222. Europe GABAA Receptor Agonists Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 223. Europe GABAA Receptor Agonists Sales by Country (2021-2026) & (k units) Table 224. Europe GABAA Receptor Agonists Sales by Country (2027-2032) & (k units) Table 225. Europe GABAA Receptor Agonists Sales Price by Country (2021-2026) & (US$/unit) Table 226. Europe GABAA Receptor Agonists Sales Price by Country (2027-2032) & (US$/unit) Table 227. Germany GABAA Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 228. France GABAA Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 229. U.K. GABAA Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 230. Italy GABAA Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 231. Russia GABAA Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 232. Spain GABAA Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 233. Netherlands GABAA Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 234. Switzerland GABAA Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 235. Sweden GABAA Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 236. Poland GABAA Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 237. China GABAA Receptor Agonists Revenue by Type (2021-2026) & (US$ Million) Table 238. China GABAA Receptor Agonists Revenue by Type (2027-2032) & (US$ Million) Table 239. China GABAA Receptor Agonists Sales by Type (2021-2026) & (k units) Table 240. China GABAA Receptor Agonists Sales by Type (2027-2032) & (k units) Table 241. China GABAA Receptor Agonists Sales Price by Type (2021-2026) & (US$/unit) Table 242. China GABAA Receptor Agonists Sales Price by Type (2027-2032) & (US$/unit) Table 243. China GABAA Receptor Agonists Revenue by Application (2021-2026) & (US$ Million) Table 244. China GABAA Receptor Agonists Revenue by Application (2027-2032) & (US$ Million) Table 245. China GABAA Receptor Agonists Sales by Application (2021-2026) & (k units) Table 246. China GABAA Receptor Agonists Sales by Application (2027-2032) & (k units) Table 247. China GABAA Receptor Agonists Sales Price by Application (2021-2026) & (US$/unit) Table 248. China GABAA Receptor Agonists Sales Price by Application (2027-2032) & (US$/unit) Table 249. Asia GABAA Receptor Agonists Revenue by Type (2021-2026) & (US$ Million) Table 250. Asia GABAA Receptor Agonists Revenue by Type (2027-2032) & (US$ Million) Table 251. Asia GABAA Receptor Agonists Sales by Type (2021-2026) & (k units) Table 252. Asia GABAA Receptor Agonists Sales by Type (2027-2032) & (k units) Table 253. Asia GABAA Receptor Agonists Sales Price by Type (2021-2026) & (US$/unit) Table 254. Asia GABAA Receptor Agonists Sales Price by Type (2027-2032) & (US$/unit) Table 255. Asia GABAA Receptor Agonists Revenue by Application (2021-2026) & (US$ Million) Table 256. Asia GABAA Receptor Agonists Revenue by Application (2027-2032) & (US$ Million) Table 257. Asia GABAA Receptor Agonists Sales by Application (2021-2026) & (k units) Table 258. Asia GABAA Receptor Agonists Sales by Application (2027-2032) & (k units) Table 259. Asia GABAA Receptor Agonists Sales Price by Application (2021-2026) & (US$/unit) Table 260. Asia GABAA Receptor Agonists Sales Price by Application (2027-2032) & (US$/unit) Table 261. Asia GABAA Receptor Agonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 262. Asia GABAA Receptor Agonists Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 263. Asia GABAA Receptor Agonists Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 264. Asia GABAA Receptor Agonists Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 265. Asia GABAA Receptor Agonists Sales by Country (2021-2026) & (k units) Table 266. Asia GABAA Receptor Agonists Sales by Country (2027-2032) & (k units) Table 267. Asia GABAA Receptor Agonists Sales Price by Country (2021-2026) & (US$/unit) Table 268. Asia GABAA Receptor Agonists Sales Price by Country (2027-2032) & (US$/unit) Table 269. Japan GABAA Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 270. South Korea GABAA Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 271. India GABAA Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 272. Australia GABAA Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 273. Taiwan GABAA Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 274. Southeast Asia GABAA Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 275. SAMEA GABAA Receptor Agonists Revenue by Type (2021-2026) & (US$ Million) Table 276. SAMEA GABAA Receptor Agonists Revenue by Type (2027-2032) & (US$ Million) Table 277. SAMEA GABAA Receptor Agonists Sales by Type (2021-2026) & (k units) Table 278. SAMEA GABAA Receptor Agonists Sales by Type (2027-2032) & (k units) Table 279. SAMEA GABAA Receptor Agonists Sales Price by Type (2021-2026) & (US$/unit) Table 280. SAMEA GABAA Receptor Agonists Sales Price by Type (2027-2032) & (US$/unit) Table 281. SAMEA GABAA Receptor Agonists Revenue by Application (2021-2026) & (US$ Million) Table 282. SAMEA GABAA Receptor Agonists Revenue by Application (2027-2032) & (US$ Million) Table 283. SAMEA GABAA Receptor Agonists Sales by Application (2021-2026) & (k units) Table 284. SAMEA GABAA Receptor Agonists Sales by Application (2027-2032) & (k units) Table 285. SAMEA GABAA Receptor Agonists Sales Price by Application (2021-2026) & (US$/unit) Table 286. SAMEA GABAA Receptor Agonists Sales Price by Application (2027-2032) & (US$/unit) Table 287. SAMEA GABAA Receptor Agonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 288. SAMEA GABAA Receptor Agonists Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 289. SAMEA GABAA Receptor Agonists Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 290. SAMEA GABAA Receptor Agonists Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 291. SAMEA GABAA Receptor Agonists Sales by Country (2021-2026) & (k units) Table 292. SAMEA GABAA Receptor Agonists Sales by Country (2027-2032) & (k units) Table 293. SAMEA GABAA Receptor Agonists Sales Price by Country (2021-2026) & (US$/unit) Table 294. SAMEA GABAA Receptor Agonists Sales Price by Country (2027-2032) & (US$/unit) Table 295. Brazil GABAA Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 296. Argentina GABAA Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 297. Chile GABAA Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 298. Colombia GABAA Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 299. Peru GABAA Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 300. Saudi Arabia GABAA Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 301. Israel GABAA Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 302. UAE GABAA Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 303. Turkey GABAA Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 304. Iran GABAA Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 305. Egypt GABAA Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 306. Key Raw Materials Table 307. Raw Materials Key Suppliers Table 308. GABAA Receptor Agonists Distributors List Table 309. GABAA Receptor Agonists Customers List Table 310. Research Programs/Design for This Report Table 311. Authors List of This Report Table 312. Secondary Sources Table 313. Primary Sources List of Figures Figure 1. GABAA Receptor Agonists Image Figure 2. Global GABAA Receptor Agonists Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GABAA Receptor Agonists Market Size Share 2021 VS 2025 VS 2032 Figure 4. BZDs Image Figure 5. Non-BZDs Image Figure 6. Global GABAA Receptor Agonists Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global GABAA Receptor Agonists Market Size Share 2021 VS 2025 VS 2032 Figure 8. Epilepsy Image Figure 9. Anxiety Image Figure 10. Neuropathic Pain Image Figure 11. Insomnia Image Figure 12. Other Image Figure 13. Global GABAA Receptor Agonists Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global GABAA Receptor Agonists Revenue (2021-2032) & (US$ Million) Figure 15. Global GABAA Receptor Agonists Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global GABAA Receptor Agonists Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global GABAA Receptor Agonists Revenue Market Share by Region (2021-2032) Figure 18. Global GABAA Receptor Agonists Sales (2021-2032) & (k units) Figure 19. Global GABAA Receptor Agonists Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 20. Global GABAA Receptor Agonists Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico GABAA Receptor Agonists Sales YoY (2021-2032) & (k units) Figure 22. Europe GABAA Receptor Agonists Sales YoY (2021-2032) & (k units) Figure 23. China GABAA Receptor Agonists Sales YoY (2021-2032) & (k units) Figure 24. Asia (Excluding China) GABAA Receptor Agonists Sales YoY (2021-2032) & (k units) Figure 25. South America, Middle East and Africa GABAA Receptor Agonists Sales YoY (2021-2032) & (k units) Figure 26. Global GABAA Receptor Agonists Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global GABAA Receptor Agonists Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global GABAA Receptor Agonists Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global GABAA Receptor Agonists Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global GABAA Receptor Agonists Revenue Market Share by Type (2021-2032) Figure 32. Global GABAA Receptor Agonists Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 33. Global GABAA Receptor Agonists Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global GABAA Receptor Agonists Sales Market Share by Type (2021-2032) Figure 35. Global GABAA Receptor Agonists Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global GABAA Receptor Agonists Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global GABAA Receptor Agonists Revenue Market Share by Application (2021-2032) Figure 38. Global GABAA Receptor Agonists Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 39. Global GABAA Receptor Agonists Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global GABAA Receptor Agonists Sales Market Share by Application (2021-2032) Figure 41. North America GABAA Receptor Agonists Revenue Share by Type (2021-2032) Figure 42. North America GABAA Receptor Agonists Sales Share by Type (2021-2032) Figure 43. North America GABAA Receptor Agonists Revenue Share by Application (2021-2032) Figure 44. North America GABAA Receptor Agonists Sales Share by Application (2021-2032) Figure 45. North America GABAA Receptor Agonists Revenue Share by Country (2021-2032) Figure 46. North America GABAA Receptor Agonists Sales Share by Country (2021-2032) Figure 47. Europe GABAA Receptor Agonists Revenue Share by Type (2021-2032) Figure 48. Europe GABAA Receptor Agonists Sales Share by Type (2021-2032) Figure 49. Europe GABAA Receptor Agonists Revenue Share by Application (2021-2032) Figure 50. Europe GABAA Receptor Agonists Sales Share by Application (2021-2032) Figure 51. Europe GABAA Receptor Agonists Revenue Share by Country (2021-2032) Figure 52. Europe GABAA Receptor Agonists Sales Share by Country (2021-2032) Figure 53. China GABAA Receptor Agonists Revenue Share by Type (2021-2032) Figure 54. China GABAA Receptor Agonists Sales Share by Type (2021-2032) Figure 55. China GABAA Receptor Agonists Revenue Share by Application (2021-2032) Figure 56. China GABAA Receptor Agonists Sales Share by Application (2021-2032) Figure 57. Asia GABAA Receptor Agonists Revenue Share by Type (2021-2032) Figure 58. Asia GABAA Receptor Agonists Sales Share by Type (2021-2032) Figure 59. Asia GABAA Receptor Agonists Revenue Share by Application (2021-2032) Figure 60. Asia GABAA Receptor Agonists Sales Share by Application (2021-2032) Figure 61. Asia GABAA Receptor Agonists Revenue Share by Country (2021-2032) Figure 62. Asia GABAA Receptor Agonists Sales Share by Country (2021-2032) Figure 63. SAMEA GABAA Receptor Agonists Revenue Share by Type (2021-2032) Figure 64. SAMEA GABAA Receptor Agonists Sales Share by Type (2021-2032) Figure 65. SAMEA GABAA Receptor Agonists Revenue Share by Application (2021-2032) Figure 66. SAMEA GABAA Receptor Agonists Sales Share by Application (2021-2032) Figure 67. SAMEA GABAA Receptor Agonists Revenue Share by Country (2021-2032) Figure 68. SAMEA GABAA Receptor Agonists Sales Share by Country (2021-2032) Figure 69. GABAA Receptor Agonists Value Chain Figure 70. Manufacturing Cost Structure Figure 71. GABAA Receptor Agonists Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • BZDs
  • Non-BZDs
Applications
  • Epilepsy
  • Anxiety
  • Neuropathic Pain
  • Insomnia
  • Other
Companies covered
  • Takeda
  • Teva
  • Sun Pharma
  • Shanghai Pharmaceuticals Holding
  • Sandoz
  • Sanofi
  • Novartis
  • Mylan
  • Roche
  • Pfizer
  • Huazhong Pharmaceutical
  • Sichuan HaiscoPharmaceuical
  • GSK
  • Fresenius Kabi
  • Changzhou Siyao Pharmaceutical
  • AstraZeneca
  • WG Critical Care
  • Viatris
  • Torrent Pharma
  • SAGE Therapeutics
  • Neurelis
  • Hikma
  • CHEPLAPHARM
  • Apotex
  • Akorn

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 GABAA Receptor Agonists Market by Type
  3. 1.2.1 Global GABAA Receptor Agonists Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 BZDs
  5. 1.2.3 Non-BZDs
  6. 1.3 GABAA Receptor Agonists Market by Application
  7. 1.3.1 Global GABAA Receptor Agonists Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Epilepsy
  9. 1.3.3 Anxiety
  10. 1.3.4 Neuropathic Pain
  11. 1.3.5 Insomnia
  12. 1.3.6 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 GABAA Receptor Agonists Market Dynamics
  1. 2.1 GABAA Receptor Agonists Industry Trends
  2. 2.2 GABAA Receptor Agonists Industry Drivers
  3. 2.3 GABAA Receptor Agonists Industry Opportunities and Challenges
  4. 2.4 GABAA Receptor Agonists Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global GABAA Receptor Agonists Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global GABAA Receptor Agonists Revenue by Region
  3. 3.2.1 Global GABAA Receptor Agonists Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global GABAA Receptor Agonists Revenue by Region (2021-2026)
  5. 3.2.3 Global GABAA Receptor Agonists Revenue by Region (2027-2032)
  6. 3.2.4 Global GABAA Receptor Agonists Revenue Market Share by Region (2021-2032)
  7. 3.3 Global GABAA Receptor Agonists Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global GABAA Receptor Agonists Sales by Region
  9. 3.4.1 Global GABAA Receptor Agonists Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global GABAA Receptor Agonists Sales by Region (2021-2026)
  11. 3.4.3 Global GABAA Receptor Agonists Sales by Region (2027-2032)
  12. 3.4.4 Global GABAA Receptor Agonists Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global GABAA Receptor Agonists Revenue by Manufacturers
  2. 4.1.1 Global GABAA Receptor Agonists Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global GABAA Receptor Agonists Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global GABAA Receptor Agonists Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global GABAA Receptor Agonists Sales by Manufacturers
  6. 4.2.1 Global GABAA Receptor Agonists Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global GABAA Receptor Agonists Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global GABAA Receptor Agonists Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global GABAA Receptor Agonists Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global GABAA Receptor Agonists Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global GABAA Receptor Agonists Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global GABAA Receptor Agonists Manufacturers, Product Type & Application
  13. 4.7 Global GABAA Receptor Agonists Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global GABAA Receptor Agonists Market CR5 and HHI
  16. 4.8.2 2025 GABAA Receptor Agonists Tier 1, Tier 2, and Tier 3
5 GABAA Receptor Agonists Market by Type
  1. 5.1 Global GABAA Receptor Agonists Revenue by Type
  2. 5.1.1 Global GABAA Receptor Agonists Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global GABAA Receptor Agonists Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global GABAA Receptor Agonists Revenue Market Share by Type (2021-2032)
  5. 5.2 Global GABAA Receptor Agonists Sales by Type
  6. 5.2.1 Global GABAA Receptor Agonists Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global GABAA Receptor Agonists Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global GABAA Receptor Agonists Sales Market Share by Type (2021-2032)
  9. 5.3 Global GABAA Receptor Agonists Price by Type
6 GABAA Receptor Agonists Market by Application
  1. 6.1 Global GABAA Receptor Agonists Revenue by Application
  2. 6.1.1 Global GABAA Receptor Agonists Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global GABAA Receptor Agonists Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global GABAA Receptor Agonists Revenue Market Share by Application (2021-2032)
  5. 6.2 Global GABAA Receptor Agonists Sales by Application
  6. 6.2.1 Global GABAA Receptor Agonists Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global GABAA Receptor Agonists Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global GABAA Receptor Agonists Sales Market Share by Application (2021-2032)
  9. 6.3 Global GABAA Receptor Agonists Price by Application
7 Company Profiles
  1. 7.1 Takeda
  2. 7.1.1 Takeda Company Information
  3. 7.1.2 Takeda Business Overview
  4. 7.1.3 Takeda GABAA Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Takeda GABAA Receptor Agonists Product Portfolio
  6. 7.1.5 Takeda Recent Developments
  7. 7.2 Teva
  8. 7.2.1 Teva Company Information
  9. 7.2.2 Teva Business Overview
  10. 7.2.3 Teva GABAA Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Teva GABAA Receptor Agonists Product Portfolio
  12. 7.2.5 Teva Recent Developments
  13. 7.3 Sun Pharma
  14. 7.3.1 Sun Pharma Company Information
  15. 7.3.2 Sun Pharma Business Overview
  16. 7.3.3 Sun Pharma GABAA Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sun Pharma GABAA Receptor Agonists Product Portfolio
  18. 7.3.5 Sun Pharma Recent Developments
  19. 7.4 Shanghai Pharmaceuticals Holding
  20. 7.4.1 Shanghai Pharmaceuticals Holding Company Information
  21. 7.4.2 Shanghai Pharmaceuticals Holding Business Overview
  22. 7.4.3 Shanghai Pharmaceuticals Holding GABAA Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Shanghai Pharmaceuticals Holding GABAA Receptor Agonists Product Portfolio
  24. 7.4.5 Shanghai Pharmaceuticals Holding Recent Developments
  25. 7.5 Sandoz
  26. 7.5.1 Sandoz Company Information
  27. 7.5.2 Sandoz Business Overview
  28. 7.5.3 Sandoz GABAA Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Sandoz GABAA Receptor Agonists Product Portfolio
  30. 7.5.5 Sandoz Recent Developments
  31. 7.6 Sanofi
  32. 7.6.1 Sanofi Company Information
  33. 7.6.2 Sanofi Business Overview
  34. 7.6.3 Sanofi GABAA Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Sanofi GABAA Receptor Agonists Product Portfolio
  36. 7.6.5 Sanofi Recent Developments
  37. 7.7 Novartis
  38. 7.7.1 Novartis Company Information
  39. 7.7.2 Novartis Business Overview
  40. 7.7.3 Novartis GABAA Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Novartis GABAA Receptor Agonists Product Portfolio
  42. 7.7.5 Novartis Recent Developments
  43. 7.8 Mylan
  44. 7.8.1 Mylan Company Information
  45. 7.8.2 Mylan Business Overview
  46. 7.8.3 Mylan GABAA Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Mylan GABAA Receptor Agonists Product Portfolio
  48. 7.8.5 Mylan Recent Developments
  49. 7.9 Roche
  50. 7.9.1 Roche Company Information
  51. 7.9.2 Roche Business Overview
  52. 7.9.3 Roche GABAA Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Roche GABAA Receptor Agonists Product Portfolio
  54. 7.9.5 Roche Recent Developments
  55. 7.10 Pfizer
  56. 7.10.1 Pfizer Company Information
  57. 7.10.2 Pfizer Business Overview
  58. 7.10.3 Pfizer GABAA Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Pfizer GABAA Receptor Agonists Product Portfolio
  60. 7.10.5 Pfizer Recent Developments
  61. 7.11 Huazhong Pharmaceutical
  62. 7.11.1 Huazhong Pharmaceutical Company Information
  63. 7.11.2 Huazhong Pharmaceutical Business Overview
  64. 7.11.3 Huazhong Pharmaceutical GABAA Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Huazhong Pharmaceutical GABAA Receptor Agonists Product Portfolio
  66. 7.11.5 Huazhong Pharmaceutical Recent Developments
  67. 7.12 Sichuan HaiscoPharmaceuical
  68. 7.12.1 Sichuan HaiscoPharmaceuical Company Information
  69. 7.12.2 Sichuan HaiscoPharmaceuical Business Overview
  70. 7.12.3 Sichuan HaiscoPharmaceuical GABAA Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Sichuan HaiscoPharmaceuical GABAA Receptor Agonists Product Portfolio
  72. 7.12.5 Sichuan HaiscoPharmaceuical Recent Developments
  73. 7.13 GSK
  74. 7.13.1 GSK Company Information
  75. 7.13.2 GSK Business Overview
  76. 7.13.3 GSK GABAA Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 GSK GABAA Receptor Agonists Product Portfolio
  78. 7.13.5 GSK Recent Developments
  79. 7.14 Fresenius Kabi
  80. 7.14.1 Fresenius Kabi Company Information
  81. 7.14.2 Fresenius Kabi Business Overview
  82. 7.14.3 Fresenius Kabi GABAA Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Fresenius Kabi GABAA Receptor Agonists Product Portfolio
  84. 7.14.5 Fresenius Kabi Recent Developments
  85. 7.15 Changzhou Siyao Pharmaceutical
  86. 7.15.1 Changzhou Siyao Pharmaceutical Company Information
  87. 7.15.2 Changzhou Siyao Pharmaceutical Business Overview
  88. 7.15.3 Changzhou Siyao Pharmaceutical GABAA Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Changzhou Siyao Pharmaceutical GABAA Receptor Agonists Product Portfolio
  90. 7.15.5 Changzhou Siyao Pharmaceutical Recent Developments
  91. 7.16 AstraZeneca
  92. 7.16.1 AstraZeneca Company Information
  93. 7.16.2 AstraZeneca Business Overview
  94. 7.16.3 AstraZeneca GABAA Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 AstraZeneca GABAA Receptor Agonists Product Portfolio
  96. 7.16.5 AstraZeneca Recent Developments
  97. 7.17 WG Critical Care
  98. 7.17.1 WG Critical Care Company Information
  99. 7.17.2 WG Critical Care Business Overview
  100. 7.17.3 WG Critical Care GABAA Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 WG Critical Care GABAA Receptor Agonists Product Portfolio
  102. 7.17.5 WG Critical Care Recent Developments
  103. 7.18 Viatris
  104. 7.18.1 Viatris Company Information
  105. 7.18.2 Viatris Business Overview
  106. 7.18.3 Viatris GABAA Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Viatris GABAA Receptor Agonists Product Portfolio
  108. 7.18.5 Viatris Recent Developments
  109. 7.19 Torrent Pharma
  110. 7.19.1 Torrent Pharma Company Information
  111. 7.19.2 Torrent Pharma Business Overview
  112. 7.19.3 Torrent Pharma GABAA Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Torrent Pharma GABAA Receptor Agonists Product Portfolio
  114. 7.19.5 Torrent Pharma Recent Developments
  115. 7.20 SAGE Therapeutics
  116. 7.20.1 SAGE Therapeutics Company Information
  117. 7.20.2 SAGE Therapeutics Business Overview
  118. 7.20.3 SAGE Therapeutics GABAA Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 SAGE Therapeutics GABAA Receptor Agonists Product Portfolio
  120. 7.20.5 SAGE Therapeutics Recent Developments
  121. 7.21 Neurelis
  122. 7.21.1 Neurelis Company Information
  123. 7.21.2 Neurelis Business Overview
  124. 7.21.3 Neurelis GABAA Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Neurelis GABAA Receptor Agonists Product Portfolio
  126. 7.21.5 Neurelis Recent Developments
  127. 7.22 Hikma
  128. 7.22.1 Hikma Company Information
  129. 7.22.2 Hikma Business Overview
  130. 7.22.3 Hikma GABAA Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Hikma GABAA Receptor Agonists Product Portfolio
  132. 7.22.5 Hikma Recent Developments
  133. 7.23 CHEPLAPHARM
  134. 7.23.1 CHEPLAPHARM Company Information
  135. 7.23.2 CHEPLAPHARM Business Overview
  136. 7.23.3 CHEPLAPHARM GABAA Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 CHEPLAPHARM GABAA Receptor Agonists Product Portfolio
  138. 7.23.5 CHEPLAPHARM Recent Developments
  139. 7.24 Apotex
  140. 7.24.1 Apotex Company Information
  141. 7.24.2 Apotex Business Overview
  142. 7.24.3 Apotex GABAA Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  143. 7.24.4 Apotex GABAA Receptor Agonists Product Portfolio
  144. 7.24.5 Apotex Recent Developments
  145. 7.25 Akorn
  146. 7.25.1 Akorn Company Information
  147. 7.25.2 Akorn Business Overview
  148. 7.25.3 Akorn GABAA Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  149. 7.25.4 Akorn GABAA Receptor Agonists Product Portfolio
  150. 7.25.5 Akorn Recent Developments
8 North America
  1. 8.1 North America GABAA Receptor Agonists Market Size by Type
  2. 8.1.1 North America GABAA Receptor Agonists Revenue by Type (2021-2032)
  3. 8.1.2 North America GABAA Receptor Agonists Sales by Type (2021-2032)
  4. 8.1.3 North America GABAA Receptor Agonists Price by Type (2021-2032)
  5. 8.2 North America GABAA Receptor Agonists Market Size by Application
  6. 8.2.1 North America GABAA Receptor Agonists Revenue by Application (2021-2032)
  7. 8.2.2 North America GABAA Receptor Agonists Sales by Application (2021-2032)
  8. 8.2.3 North America GABAA Receptor Agonists Price by Application (2021-2032)
  9. 8.3 North America GABAA Receptor Agonists Market Size by Country
  10. 8.3.1 North America GABAA Receptor Agonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America GABAA Receptor Agonists Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America GABAA Receptor Agonists Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe GABAA Receptor Agonists Market Size by Type
  2. 9.1.1 Europe GABAA Receptor Agonists Revenue by Type (2021-2032)
  3. 9.1.2 Europe GABAA Receptor Agonists Sales by Type (2021-2032)
  4. 9.1.3 Europe GABAA Receptor Agonists Price by Type (2021-2032)
  5. 9.2 Europe GABAA Receptor Agonists Market Size by Application
  6. 9.2.1 Europe GABAA Receptor Agonists Revenue by Application (2021-2032)
  7. 9.2.2 Europe GABAA Receptor Agonists Sales by Application (2021-2032)
  8. 9.2.3 Europe GABAA Receptor Agonists Price by Application (2021-2032)
  9. 9.3 Europe GABAA Receptor Agonists Market Size by Country
  10. 9.3.1 Europe GABAA Receptor Agonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe GABAA Receptor Agonists Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe GABAA Receptor Agonists Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China GABAA Receptor Agonists Market Size by Type
  2. 10.1.1 China GABAA Receptor Agonists Revenue by Type (2021-2032)
  3. 10.1.2 China GABAA Receptor Agonists Sales by Type (2021-2032)
  4. 10.1.3 China GABAA Receptor Agonists Price by Type (2021-2032)
  5. 10.2 China GABAA Receptor Agonists Market Size by Application
  6. 10.2.1 China GABAA Receptor Agonists Revenue by Application (2021-2032)
  7. 10.2.2 China GABAA Receptor Agonists Sales by Application (2021-2032)
  8. 10.2.3 China GABAA Receptor Agonists Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia GABAA Receptor Agonists Market Size by Type
  2. 11.1.1 Asia GABAA Receptor Agonists Revenue by Type (2021-2032)
  3. 11.1.2 Asia GABAA Receptor Agonists Sales by Type (2021-2032)
  4. 11.1.3 Asia GABAA Receptor Agonists Price by Type (2021-2032)
  5. 11.2 Asia GABAA Receptor Agonists Market Size by Application
  6. 11.2.1 Asia GABAA Receptor Agonists Revenue by Application (2021-2032)
  7. 11.2.2 Asia GABAA Receptor Agonists Sales by Application (2021-2032)
  8. 11.2.3 Asia GABAA Receptor Agonists Price by Application (2021-2032)
  9. 11.3 Asia GABAA Receptor Agonists Market Size by Country
  10. 11.3.1 Asia GABAA Receptor Agonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia GABAA Receptor Agonists Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia GABAA Receptor Agonists Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA GABAA Receptor Agonists Market Size by Type
  2. 12.1.1 SAMEA GABAA Receptor Agonists Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA GABAA Receptor Agonists Sales by Type (2021-2032)
  4. 12.1.3 SAMEA GABAA Receptor Agonists Price by Type (2021-2032)
  5. 12.2 SAMEA GABAA Receptor Agonists Market Size by Application
  6. 12.2.1 SAMEA GABAA Receptor Agonists Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA GABAA Receptor Agonists Sales by Application (2021-2032)
  8. 12.2.3 SAMEA GABAA Receptor Agonists Price by Application (2021-2032)
  9. 12.3 SAMEA GABAA Receptor Agonists Market Size by Country
  10. 12.3.1 SAMEA GABAA Receptor Agonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA GABAA Receptor Agonists Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA GABAA Receptor Agonists Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 GABAA Receptor Agonists Value Chain Analysis
  2. 13.1.1 GABAA Receptor Agonists Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 GABAA Receptor Agonists Production Mode & Process
  6. 13.2 GABAA Receptor Agonists Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 GABAA Receptor Agonists Distributors
  9. 13.2.3 GABAA Receptor Agonists Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst